Author: admin

(Bloomberg) — The Bank of Japan kept its benchmark rate unchanged and cited worries over the potential impact from US tariff policies, suggesting that it’s not in a rush to hike for now. Most Read from Bloomberg The central bank added a reference to trade policies to its list of risks to the outlook, its statement showed Wednesday. With around two weeks to go before details of President Donald Trump’s additional reciprocal tariffs come out, Governor Kazuo Ueda’s board voted to keep the policy rate steady at 0.5% at the end of a two-day gathering, a result that was in…

Accounting and business advisory firm Bober Markey Fedorovich (BMF) has elevated Kristian Barr and Michael Bigler from senior managers to directors in the Assurance and Advisory Department of its Northeast Ohio team. Barr, who has been with BMF for several years, specialises in the nonprofit industry as well as client accounting and advisory services (CAAS). Barr is known for his deep knowledge of nonprofit financial reporting, grant compliance, and audit processes. His expertise also extends to the for-profit sector, where he offers financial forecasting, internal control assessments, and acquisition due diligence. In his role within the CAAS group, Barr will…

(Bloomberg) — Oil fell for a second day after an industry report showed US crude stockpiles increased against a backdrop of concerns about global economic growth. Most Read from Bloomberg West Texas Intermediate crude slid toward $66 a barrel. The American Petroleum Institute said nationwide inventories rose by 4.6 million barrels last week, although a draw was seen at the key hub in Cushing, Oklahoma. Official data are due later on Wednesday. Investors will also watch for a Federal Reserve interest-rate decision, plus commentary from Chair Jerome Powell on the economy as President Donald Trump amps up his trade war.…

US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical gel 10% for treating mild-to-moderate actinic keratoses (AKs). The randomised, double-blind trial is comparing Ameluz with a vehicle gel in treating AK on the extremities, neck and trunk, using the RhodoLED lamp photodynamic therapy (PDT). It has been designed to evaluate Ameluz’s efficacy and safety as a PDT after the application of one to three tubes of the product on surface areas of nearly 80cm², 160cm² or 240cm². Subjects who still have at least one lesion after receiving either Ameluz…

(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs in the US. Most Read from Bloomberg Exports measured by value gained 11.4% in February from a year earlier, the Ministry of Finance reported Wednesday. Exports slightly missed the median estimate of a 12.6% increase. Imports fell 0.7%, compared with the median estimate of a 0.8% gain. Japan’s trade balance switched back into the black, with a surplus of ¥584.5 billion ($3.9 billion). Trade helped Japan’s economy grow in the last quarter of 2024 as net exports rose, and shipments…

US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical gel 10% for treating mild-to-moderate actinic keratoses (AKs). The randomised, double-blind trial is comparing Ameluz with a vehicle gel in treating AK on the extremities, neck and trunk, using the RhodoLED lamp photodynamic therapy (PDT). It has been designed to evaluate Ameluz’s efficacy and safety as a PDT after the application of one to three tubes of the product on surface areas of nearly 80cm², 160cm² or 240cm². Subjects who still have at least one lesion after receiving either Ameluz…

(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs in the US. Most Read from Bloomberg Exports measured by value gained 11.4% in February from a year earlier, the Ministry of Finance reported Wednesday. Exports slightly missed the median estimate of a 12.6% increase. Imports fell 0.7%, compared with the median estimate of a 0.8% gain. Japan’s trade balance switched back into the black, with a surplus of ¥584.5 billion ($3.9 billion). Trade helped Japan’s economy grow in the last quarter of 2024 as net exports rose, and shipments…

US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical gel 10% for treating mild-to-moderate actinic keratoses (AKs). The randomised, double-blind trial is comparing Ameluz with a vehicle gel in treating AK on the extremities, neck and trunk, using the RhodoLED lamp photodynamic therapy (PDT). It has been designed to evaluate Ameluz’s efficacy and safety as a PDT after the application of one to three tubes of the product on surface areas of nearly 80cm², 160cm² or 240cm². Subjects who still have at least one lesion after receiving either Ameluz…

(Bloomberg) — Japan’s exports rose at a faster pace as businesses increased orders ahead of the rollout of higher tariffs in the US. Most Read from Bloomberg Exports measured by value gained 11.4% in February from a year earlier, the Ministry of Finance reported Wednesday. Exports slightly missed the median estimate of a 12.6% increase. Imports fell 0.7%, compared with the median estimate of a 0.8% gain. Japan’s trade balance switched back into the black, with a surplus of ¥584.5 billion ($3.9 billion). Trade helped Japan’s economy grow in the last quarter of 2024 as net exports rose, and shipments…

US-based biopharmaceutical company Biofrontera has finished enrolling subjects in its multicentre Phase III trial of Ameluz (aminolevulinic acid hydrochloride) topical gel 10% for treating mild-to-moderate actinic keratoses (AKs). The randomised, double-blind trial is comparing Ameluz with a vehicle gel in treating AK on the extremities, neck and trunk, using the RhodoLED lamp photodynamic therapy (PDT). It has been designed to evaluate Ameluz’s efficacy and safety as a PDT after the application of one to three tubes of the product on surface areas of nearly 80cm², 160cm² or 240cm². Subjects who still have at least one lesion after receiving either Ameluz…